Allakos Revenue and Competitors
Estimated Revenue & Valuation
- Allakos's estimated annual revenue is currently $6.5M per year.
- Allakos received $100.0M in venture funding in December 2017.
- Allakos's estimated revenue per employee is $48,947
- Allakos's total funding is $162.4M.
- Allakos's current valuation is $415M. (January 2022)
Employee Data
- Allakos has 133 Employees.
- Allakos grew their employee count by 2% last year.
Allakos's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Sr. VP Regulatory Affairs and Clinical Compliance | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | VP, Head Clinical Operations | Reveal Email/Phone |
4 | VP, Asset Leadership and Head Commercial Strategy | Reveal Email/Phone |
5 | Head Health Economics and Outcomes Research (HEOR) | Reveal Email/Phone |
6 | VP Sales | Reveal Email/Phone |
7 | VP, Chief Accountant | Reveal Email/Phone |
8 | SVP and Head Technical Operations | Reveal Email/Phone |
9 | VP, Head Quality | Reveal Email/Phone |
10 | VP, Venture Investing, Roche Venture Fund | Reveal Email/Phone |
Allakos Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 5 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 4 | -50% | N/A | N/A |
#6 | $0.7M | 8 | 0% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 17 | 31% | N/A | N/A |
What Is Allakos?
Allakos Inc. is a publicly traded clinical-stage biopharmaceutical company developing first-in-class antibody-based therapeutics to treat allergic and inflammatory diseases.
keywords:Biotechnology,Cleantech,Healthcare,Marketing,Pharmaceuticals,Wind Power
$162.4M
Total Funding
133
Number of Employees
$6.5M
Revenue (est)
2%
Employee Growth %
$415M
Valuation
N/A
Accelerator
Allakos News
(b) On April 15, 2022 , Mark Asbury informed Allakos Inc. (the "Company") of his decision to retire from his position as Chief Legal Officer and...
Before Allakos, John held financial planning and analytics positions at Jaguar Health, BioMarin Pharmaceuticals, and Avinger, Inc. Earlier in...
Allakos logo Equities analysts forecast that Allakos Inc. (NASDAQ:ALLK Get Rating) will announce earnings of ($1.71) per share for the...
SG Americas Securities LLC increased its stake in shares of Allakos Inc (NASDAQ:ALLK) by 27.5% during the 2nd quarter, according to the ...
Other Companies in San Carlos
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $33.1M | 135 | 7% | N/A |
#2 | $34.4M | 137 | 9% | $23M |
#3 | $21.1M | 140 | -8% | $103.6M |
#4 | $38.2M | 143 | 1% | $158.3M |
#5 | $28.5M | 149 | N/A | N/A |
Allakos Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2014-10-01 | $10.0M | Undisclosed | Multiple | Article |
| 2017-12-14 | $100.0M | A | New Enterprise Associates | Article |